Tabula Rasa HealthCare to Host Call to Discuss AJMC Publications

Rhea-AI Summary

Tabula Rasa HealthCare (TRHC) announced a conference call on September 28, 2021, at 11:00 a.m. ET, to discuss its peer-reviewed article series in The American Journal of Managed Care. The series focuses on an Innovative Enhanced Medication Therapy Management Model that aims to improve medication safety and healthcare outcomes. The call will feature CEO Calvin H. Knowlton, Chief Sales Officer Kevin Boesen, and Chief Scientific Officer Jacques Turgeon. Participants can join via phone or online at TRHC's investor site, with replay options available until October 5, 2021.

MOORESTOWN, N.J., Sept. 27, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced it will host a conference call and webcast to discuss its recently published, peer-reviewed three-part series, Innovative Enhanced Medication Therapy Management Model: Medication Risk Score, Medication Safety Review, and Health Care Outcomes, in the September issue of The American Journal of Managed Care.

The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Chief Sales Officer, Kevin Boesen, PharmD; and TRHC Chief Scientific Officer and CEO, Precision Pharmacotherapy, Research and Development Institute, Jacques Turgeon, BPharm, PhD.

Conference Call
The conference call and webcast will be held on Tuesday, September 28, 2021, at 11:00 a.m. ET. The conference call can be accessed by dialing 844-413-0947 for U.S. participants or 216-562-0423 for international participants and referencing passcode 4280419 or via a live audio webcast available online at TRHC's investor website (ir.trhc.com). A phone and audio webcast replay will be available until October 5, 2021, by at ir.trhc.com or by dialing 855-859-2056 for U.S. participants or 404-537-3406 for international participants and referencing passcode 4280419.

About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care. For more information, visit TRHC.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-to-host-call-to-discuss-ajmc-publications-301385093.html

SOURCE Tabula Rasa HealthCare, Inc.

FAQ

What is the date and time of the TRHC conference call?

The TRHC conference call is scheduled for September 28, 2021, at 11:00 a.m. ET.

Who will be hosting the TRHC conference call?

The conference call will be hosted by TRHC CEO Calvin H. Knowlton, Chief Sales Officer Kevin Boesen, and Chief Scientific Officer Jacques Turgeon.

How can I access the TRHC conference call?

You can access the TRHC conference call by dialing 844-413-0947 for U.S. participants or 216-562-0423 for international participants, or via a live audio webcast at TRHC's investor website.

What is the topic of the TRHC conference call?

The conference call will discuss TRHC's recently published peer-reviewed series on the Innovative Enhanced Medication Therapy Management Model.

When will the replay of the TRHC conference call be available?

The replay of the TRHC conference call will be available until October 5, 2021.